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Fatalities from opioid induced drug overdoses reached an all-time high in
Maine for 2016

There is over-use of opioids in the state of Maine

Only 10 % of people of people living with addiction get treatment

People taking prescription opioids often can't differentiate when they've crossed
over into abusive behavior

Patients are poorly educated about the dangers of taking opioids long term

Patients are poorly educated about the dangers of taking opioids long term

There is considerable societal stigma that addiction is not a disease , therefore
preventative measures are not seen to be as important.
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Root
Cause

New
Practice:
Public Law
Chapter 488

Old Practice: There
were no prior limits
in opioid prescribing,
required by state law.
Prescribers were
doing as they had
always done.

Due to the multifactorial
schema of addiction,
increasing the stringency of
policies for opioid
prescribers will not solve
the entire problem.
However, making sure that
all prescriptions for opioids
are in compliance with
these new standards is a
step in the right direction.

(4) Mandates electronic prescribing of opioids

(3) Mandates education for opioid prescribers

Problem

Root Cause Analysis:

Figure 1: Baseline data for total drug overdose
Deaths in the state of Maine per year, as well as
trends for overdose deaths specifically caused by
either pharmaceutical or illicit opioids.

(2) Enacts strict limits on opioid prescribing
for acute and chronic pain

(1) Mandates the use of the State’s
Prescription Monitoring Program and
expands those who use it

Current State: Public Law Chapter 488
makes 4 main changes to opioid prescribing :

Baseline Metrics/Current State:

100% of the time the Outpatient Pharmacy team at MMC, will track the number of provider phone calls made by
pharmacists to clarify opioid prescriptions and resolve any non-compliance with Chapter 488.

Goal/Objective:

In scope: Opioid prescriptions filled by Pharmacists at MMC, after January 1st, 2017
Out of scope: Opioids prescriptions not filled by Pharmacists at MMC, after January 1st, 2017

Scope:

In 2016, there were 378 opioid overdose deaths in the State of Maine, illustrating the drug epidemic that is sweeping the state, as well
as the nation, and continues worsen with each passing year. In attempt to prevent opiate abuse, the Maine Legislature passed Public
Law Chapter 488 on January 1, 2017, which acts to strengthen the controlled substances prescription monitoring program. With this
new legislation, came a new set of guidelines and protocols that would need to be implemented by pharmacists and opioid prescribers
around the state, including Maine Medical Center (MMC).

Problem/Impact Statement:

Pharmacy
Leadership Group

KPI: Second plan of action: Pharmacist has conversation with chiefs when
trends are identified, in order to have them provide the appropriate education
in opioid prescription compliance with Chapter 488.

Week 1

Week 3
January 2017

Week 2

Week 4

Status

Ongoing

Ongoing

Completed

Completed

If repeat offeders or systematic
department, chief of that department will
need to conduct education

Pharmacist directly contacts
prescriber to provide education

Assess for non‐compliance

A standardized approach to prescriber education has
been developed.

• For the state of Maine and the nation: Develop a continuous discourse about addiction as a disease ,
in an attempt to alleviate the associated stigma "

• For MMC: There is ongoing prescriber education whenever instances of noncompliance with
Chapter 488 arise, in an attempt to decrease the incidence of un-warranted prescription opioids

Next Steps

Figure 2: Percentage of Opioid prescriptions requiring follow up of a
pharmacist with the prescriber, to combat issues of non-compliance
with Chapter 488
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It has become hard wired within the Outpatient
Pharmacy at MMC to address any non-compliant
opioid prescription that is to be filled there.

Pharmacy
Leadership Group

KPI: First plan of action: Pharmacist has direct conversation with a noncompliant prescriber each time, to provide quick one-on-one education

Outcomes

Pharmacy
Leadership Group

KPI: Track number of phone calls made by pharmacists to providers to clarify
opioid prescriptions and resolve any non-compliance

Owner
Maine State
Legislature

Action

Countermeasures
Public Law Chapter 488 enacted, “An Act to Prevent Opiate Abuse by
Strengthening the Controlled Substances Prescription Monitoring Program”

Do
Study
Act

Plan
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